David Nash MD to Join Genomind’s Scientific Advisory Board
Genomind®, a leading precision healthcare company named David Nash, MD, MBA of Jefferson Health the newest member of its Scientific Advisory Board (SAB).
CEO Shawn O’Brien Interviewed on WHBQ56 Sports Radio
Shawn O’Brien joined Johnny’s Radio Happy Hour on Sports 56 to explain Mental Health Map, partnering with Kevin Love & why parents should care about their child’s genetics.
CEO Shawn O’Brien Interviewed on KAHI Radio
Genomind CEO Shawn Patrick O’Brien joins Casey Freelove of KAHI Radio in Sacramento/ Auburn, CA to discuss Genomind’s tests, mission and initiatives.
Genomind Announces Two Major Appointments
Cynthia Kilroy Named Chief Strategy & Corporate Development Officer and Stephen R Saklad, PharmD, BCCP Joins the Company’s Scientific Advisory Board.
Genomind Inc. Recruits Group of World-Renowned Experts in Psychiatry and Neurology to Advance its Commitment to Mental Health Innovation
Genomind Inc. Recruits Group of World-Renowned Experts in Psychiatry and Neurology to Advance its Commitment to Mental Health Innovation.
Genomind Strengthens its Leadership Team with Hiring of Experienced CEO, President and Internal Promotions
Shawn Patrick O’Brien and Kip Olmstead Bring Decades of Global Biotech Leadership and Marketing Experience to the King of Prussia-Based Company Disrupting Genetic Testing.
Trio of Awards Cap Ground-Breaking Year for Genomind and Its Unique Platform
Trio of Awards Cap Ground-Breaking Year for Genomind and Its Unique Platform.
Multiple Honors and Recognition for Genomind as a Record of Success Continues
Genomind continues to collect a notable set of awards as it builds on its strategic plan.
Genomind’s Industry Accolades Expand, Bolstered by a Strong Scientific Advisory Board
Genomind’s Industry Accolades Expand, Bolstered by a Strong Scientific Advisory Board.
Genomind® Reaches Milestone, Expands Headquarters to Meet Demand
Genomind announced a headquarters expansion and its Genecept Assay® has been used to aid clinicians in treating a total of over 100,000 patients.
Genomind® Receives Emerging Company of the Year Award from Life Sciences Pennsylvania
Representing the entire life sciences industry in the state, Life Sciences Pennsylvania has named Genomind its Emerging Company of the Year.
Genomind® Looks Forward to Growth in New Year as it Reflects on 2016 Accomplishments
Genomind® Looks Forward to Growth in New Year as it Reflects on 2016 Accomplishments.
Recognition Grows for Genomind as a Leader in Genetic Testing for Mental Health Treatment
Genomind, a personalized medicine company bringing innovation to mental health care through genetic testing, continues to receive awards and recognition.
Genomind Named One of the Best Places to Work in Healthcare
Genomind was recently named one of the best places to work in healthcare by Modern Healthcare Magazine and Best Companies Group.
Rep. Brendan Boyle Tour of Genomind Lab In King of Prussia to Showcase Personalized Medicine for Mental Health
Genomind lab will highlight the importance of the biotech industry to Pennsylvania when Representative Brendan Boyle tours its lab.
‘Dr. Phil’ Show to Feature Genomind’s Genecept Assay in Upcoming Program Aimed at Helping a Patient Get Better
Genomind will soon be featured in a nationally broadcast episode of “Dr. Phil”, highlighted as part of a program focused on helping a family in crisis.
Genomind’s Cutting-Edge Pharmacogenetic Testing To Be Featured On Educational “Innovations” TV Series
“Innovations,” an award-winning television series seen on the Discovery Channel, will feature Genomind in a seven-minute segment that is set to premiere Monday, Dec. 14 at 7:30 a.m. EST and 7:30 a.m.
Genomind Appoints New Chief Medical Officer as Personalized Medicine Company Advances Work on Brain Health
Genomind Appoints New Chief Medical Officer as Personalized Medicine Company Advances Work on Brain Health
Genomind is excited to appoint Rina Wolf to its Board of Directors
Genomind is excited to appoint Rina Wolf to its Board of Directors
Genomind Expands And Strengthens Leadership Team
Genomind Expands And Strengthens Leadership Team
Genomind Welcomes New Executive Team Member Thomas Hess
Genomind Welcomes New Executive Team Member Thomas Hess
Dr. Jay Lombard Of Genomind Selected To Speak At Partnering For Cures (P4C) On “Mental Health: Research And Development At A Crossroads”
Dr. Jay Lombard Of Genomind Selected To Speak At Partnering For Cures (P4C) On “Mental Health: Research And Development At A Crossroads”
Genomind Demonstrates Broader Commitment To The Mental Health Community
Genomind Demonstrates Broader Commitment To The Mental Health Community
Genomind Microsite Wins “Best In Class” Award
Genomind Microsite Wins “Best In Class” Award
Genomind Executive To Speak At Open Minds Technology & Informatics Institute
Genomind Executive To Speak At Open Minds Technology & Informatics Institute
Rudolph E. Tanzi, Ph.D. Joins Genomind’s Scientific Advisory Board
Rudolph E. Tanzi, Ph.D. Joins Genomind’s Scientific Advisory Board
Genomind Announces New Scientific Advisory Board Member
Genomind Announces New Scientific Advisory Board Member
Genomind Welcomes New Executive Team Member Hill Meade
Genomind Welcomes New Executive Team Member Hill Meade
New Chief Sales Executive To Lead Effort To Expand Adoption Of The Genecept Assay
New Chief Sales Executive To Lead Effort To Expand Adoption Of The Genecept™ Assay
Genomind Announces New Enhancements To Leadership Team
Genomind Announces New Enhancements To Leadership Team
